TITLE

Local Recurrence of Breast Cancer After MammoSite Brachytherapy

AUTHOR(S)
Voth, Matthew; Budway, Raye; Keleher, Angela; Caushaj, Philip F.
PUB. DATE
September 2006
SOURCE
American Surgeon;Sep2006, Vol. 72 Issue 9, p798
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Women undergoing breast conservation therapy (BCT) for stage I breast cancer have adjuvant external beam radiotherapy (EBR). In addition, the use of brachytherapy radiation is being used. We present two local tumor recurrences for review. Our first patient underwent BCT, sentinel lymph node biopsy (SLNBx) and MammoSite® brachytherapy for a TINOM0 infiltrating ductal carcinoma (IDC) of the right breast. Pathology: 0.6 cm poorly differentiated ER, PR, and Her-2/Neu negative IDC. At 18 months, she had palpable axillary lymph nodes. Fine needle aspiration and ultrasound-guided core biopsy of a nodule showed IDC. She underwent modified radical mastectomy (MRM) and EBR. Our second patient underwent BCT, SLNBx, and MammoSite® brachytherapy for a T1N0M0 IDC of the left breast. Pathology: 0.8 cm poorly differentiated, ER+, PR-, and Her-2/Neu negative tumor. At 18 months, a retroareolar mass was detected. Ultrasound guided core needle biopsy showed recurrent IDC. She chose a re-excision and EBR and not MRM. Pathology: 1.3 cm poorly differentiated, ER+, PR-, and Her-2/Neu negative tumor. Our 2 recurrences were >2 cm away from the lumpectomy site and therefore outside the 1 cm treatment plan of the MammoSite® catheter. Both recurrences were biologically identical to the initial tumors and are felt to be local failures rather than new primaries.
ACCESSION #
22234706

 

Related Articles

  • Addressing Overtreatment in DCIS: What Should Physicians Do Now? Morrow, Monica; Katz, Steven J. // JNCI: Journal of the National Cancer Institute;Dec2015, Vol. 107 Issue 12, p1 

    The authors present insights on the ongoing debate concerning ductal carcinoma in situ (DCIS) in relation to breast cancer overtreatment. Topics discussed include the marked increase in rates of diagnosis and the failure to reduce the incidence of invasive breast cancer, the trends in treatment...

  • Re-sentinel node biopsy after previous breast and axillary surgery. Ikeda, Tadashi // Surgery Today;Nov2014, Vol. 44 Issue 11, p2015 

    There is no consensus regarding the strategy for managing the regional lymph nodes in patients with local breast cancer recurrence. This paper reviews the updated data on re-sentinel lymph node biopsy (re-SLNB) after previous surgery. The identification rate of re-SLNB varied from 29 to 100 %...

  • Citations and Clinicians' Notes: Treatment: Novel therapies.  // Current Medical Literature: Breast Cancer;2003, Vol. 15 Issue 4, p115 

    Present information on the studies regarding therapies for breast cancer. "Risk Factors for Regional Nodal Failure After Breast-Conserving Therapy: Regional Nodal Irradiation Reduces Rate of Axillary Failure in Patients With Four Or More Positive Lymph Nodes," by I. S. Grills, L. L. Kestin, N....

  • Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. Truong, Pauline T.; Olivotto, Ivo A.; Whelan, Timothy J.; Levine, Mark // CMAJ: Canadian Medical Association Journal;4/13/2004, Vol. 170 Issue 8, p1263 

    Objective: To provide information and recommendations to assist women with breast cancer and their physicians in making de-cisions regarding the use of locoregional post-mastectomy ra-diotherapy (PMRT). Outcomes: Locoregional control, disease-free survival, overall survival and...

  • Lymphatic Mapping Improves Staging and Reduces Morbidity in Women Undergoing Total Mastectomy for Breast Carcinoma. Langer, Samantha; Guenther, J. Michael; Haigh, Philip I.; Difronzo, L. Andrew // American Surgeon;Oct2004, Vol. 70 Issue 10, p881 

    Lymphatic mapping (LM) and sentinel lymph node biopsy (SLNB) have become widely accepted in the setting of breast conservation surgery. We hypothesized that LM can be extended to women undergoing total mastectomy, being technically feasible, yielding highly accurate and sensitive results,...

  • Effect On Oximetry Of Isosulfan Blue Used For Sentinel Lymph Node Biopsy In Breast Surgery. Turkmen, Aygen; Turgut, Namigar; Guven, Hakan; Ulufi, Nalan; Altan, Aysel; Ali, Achmet; Alkan, Irem // Internet Journal of Anesthesiology;2008, Vol. 15 Issue 2, p2 

    Isosulfan blue 1% is a dye used in medical procedures such as lymphangiography and sentinel lymph node biopsy. Besides anaphylaxis, isosulfan blue dye may cause discoloration of a patient's serum making the use of pulse oximetry useless by mimicking true intraoperative hypoxia. A 70-year old...

  • Axillary sentinel lymph node biopsy after mastectomy: a case report. Vicente, Diego A.; Henry, Leonard R.; Hahm, George; Soballe, Peter W.; Smart, DeeDee // World Journal of Surgical Oncology;2010, Vol. 8, p59 

    Background: Sentinel lymph node biopsy has been established as the preferred method for staging early breast cancer. A prior history of mastectomy is felt to be a contraindication. Case presentation: A patient with recurrent breast cancer in her skin flap was discovered to have positive axillary...

  • METASTATIC MALIGNANT MELANOMA OF THE BREAST: A CASE REPORT. Nalbant, Olcay Ak; Vural, Safiye; Keleş, M. Celalettin; Nalbant, Erdem; Kandiloğlu, Ali Rıza // Meme Sagligi Dergisi / Journal of Breast Health;2011, Vol. 7 Issue 1, p36 

    Metastasis of a malignant melanoma or any other type of tumour to the breast is rarely seen. A 70-year-old female patient came to the breast clinic due to a mass in her right breast. The case did not have any known history of malignancy. After the initial incisional biopsy, a right modified...

  • Prognostic Significance of Intratumoral and Peritumoral Lymphatic Density and Blood Vessel Density in Invasive Breast Carcinomas. Yasser El-Gohary; Ghada Metwally; Reda Saad; Morton Robinson; Thomas Mesko; Robert Poppiti // American Journal of Clinical Pathology;Apr2008, Vol. 129 Issue 4, p578 

    We studied tumor lymphatic and vascular densities and lymphovascular invasion (LVI) as prognostic markers in 48 cases of invasive breast cancer treated with partial or total mastectomy and lymph node dissection. All cases were immunostained with D2-40 and CD31. Positively stained microvessels...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics